Systemic antibiotherapy in patients admitted with an acute exacerbation of COPD. Association with mortality and readmissions. Experience from the pilot study in six regions of the Nacional Clinical Audit on COPD exacerbation in Spain (AUDIPOC)

Source: Annual Congress 2010 - Pharmacological treatment in primary care

Session: Pharmacological treatment in primary care
Session type: Thematic Poster Session
Number: 858

Disease area: Airway diseases, Respiratory infections



Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. López-Arranz, C. J. Alvarez, C. Esteban Gonzalez, J. Fernández Francés, R. Agüero, J. Hueto, M. Barrón, J. A. Riesco Miranda, C. Hernandez, F. Pozo (Madrid, , Santander, Navarra, Logroño, Cáceres, Barcelona, Spain). Systemic antibiotherapy in patients admitted with an acute exacerbation of COPD. Association with mortality and readmissions. Experience from the pilot study in six regions of the Nacional Clinical Audit on COPD exacerbation in Spain (AUDIPOC). Eur Respir J 2010; 36: Suppl. 54, 858

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

• Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
• ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
• Evidence-based eHealth for COPD